LANZARONE, NICOLA
 Distribuzione geografica
Continente #
EU - Europa 1.209
NA - Nord America 1.113
AS - Asia 101
SA - Sud America 5
AF - Africa 2
OC - Oceania 2
Totale 2.432
Nazione #
US - Stati Uniti d'America 1.106
GB - Regno Unito 357
IT - Italia 262
IE - Irlanda 260
SE - Svezia 123
FR - Francia 60
DE - Germania 48
CN - Cina 43
UA - Ucraina 38
FI - Finlandia 35
IN - India 20
VN - Vietnam 18
ES - Italia 14
CA - Canada 7
IR - Iran 6
RU - Federazione Russa 4
BE - Belgio 3
CO - Colombia 3
JP - Giappone 3
TR - Turchia 3
AU - Australia 2
ID - Indonesia 2
PH - Filippine 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BR - Brasile 1
EG - Egitto 1
GR - Grecia 1
HK - Hong Kong 1
IL - Israele 1
KG - Kirghizistan 1
LT - Lituania 1
RS - Serbia 1
ZA - Sudafrica 1
Totale 2.432
Città #
Southend 336
Dublin 255
Chandler 167
Fairfield 161
Ashburn 112
Woodbridge 67
Seattle 64
Houston 61
Cambridge 58
Siena 51
Wilmington 50
New York 48
Princeton 41
Helsinki 33
Jacksonville 28
Ann Arbor 19
Fremont 19
Beijing 18
Dong Ket 18
San Mateo 18
Málaga 13
Washington 12
Padova 10
San Diego 10
Shanghai 10
Dearborn 8
London 8
Gavirate 6
Milan 6
Saint Louis 5
Como 4
Guangzhou 4
Toronto 4
Athis-mons 3
Bergamo 3
Brussels 3
Cagliari 3
Falkenstein 3
Florence 3
Izmir 3
Livorno 3
Macerata 3
Mestre 3
Nanchang 3
Nanjing 3
Naples 3
Petritoli 3
Pisa 3
Potenza 3
Scandicci 3
Trieste 3
Agliana 2
Andover 2
Arezzo 2
Berlin 2
Boardman 2
Bologna 2
Dalmine 2
Empoli 2
Genova 2
Jakarta 2
Kilburn 2
Leawood 2
Maddaloni 2
Norwalk 2
Numana 2
Olongapo City 2
Oulu 2
Pontedera 2
Porto 2
Redwood City 2
Rome 2
Serra D'aiello 2
Tokyo 2
Turin 2
Alghero 1
Bangalore 1
Belgrade 1
Bishkek 1
Bonndorf 1
Buenos Aires 1
Cairo 1
Caserta 1
Certaldo 1
Chicago 1
Colchester 1
Crotone 1
Dallas 1
Dubai 1
Genoa 1
Hangzhou 1
Hanover 1
Hounslow 1
Islington 1
Johannesburg 1
Kashan 1
Kaunas 1
Kish 1
Manresa 1
Melbourne 1
Totale 1.851
Nome #
Peripheral biomarkers' panel for severe COVID-19 patients 176
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib 169
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 152
Antithrombin III as predictive indicator of survival in IPF patients treated with Nintedanib: a preliminary study 142
Extracorporeal Photopheresis in Lung Transplantation 122
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features 119
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 117
The pharmacological treatment of bronchiectasis 116
null 113
Postoperative acute kidney injury in lung transplant recipients 110
Pirfenidone in chronic lung allograft dysfunction: a single cohort study 109
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 108
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 105
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 105
BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases 101
Krebs von den Lungen-6 as biomarker for disease severity assessment in interstitial lung disease: a comprehensive review 96
Portable Pocket-Sized Ultrasound Scanner for the Evaluation of Lung Involvement in Coronavirus Disease 2019 Patients 95
BAL and serum multiplex lipid profiling in idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis 88
Serum KL-6 levels in Pulmonary Langerhans' Cell Histiocytosis 86
Lung transplant in patients with familial pulmonary fibrosis 67
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis 60
Serial KL-6 measurements in COVID-19 patients 60
Incidenza e fattori di rischio per colonizzazione ed infezione respiratoria batterica a 30 giorni in pazienti trapiantati di polmone 48
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 29
Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis 18
Correction to: BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases (Clinical and Experimental Medicine, (2020), 20, 2, (207-216), 10.1007/s10238-020-00608-5) 3
Erratum: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis (Respiratory Research (2020) 21 (6) DOI: 10.1186/s12931-019-1263-z) 2
Totale 2.516
Categoria #
all - tutte 8.677
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.677


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201945 0 0 0 0 0 0 0 0 0 13 18 14
2019/2020261 13 4 7 11 6 13 28 37 41 30 26 45
2020/2021714 31 44 23 91 76 87 37 85 83 68 41 48
2021/2022475 25 66 55 21 25 25 18 19 17 59 59 86
2022/2023497 41 67 61 61 40 88 13 46 41 15 16 8
2023/2024496 17 6 66 44 29 157 153 12 4 8 0 0
Totale 2.516